Avanza Fonder Ab Amgen Inc Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Amgen Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 50,148 shares of AMGN stock, worth $14.7 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
50,148
Previous 59,122
15.18%
Holding current value
$14.7 Million
Previous $15.4 Billion
0.51%
% of portfolio
0.5%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,211Shares Held
421MCall Options Held
7.05MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$15.5 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.65 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.28 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.88 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $157B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...